- Home
- HL vs ASND Comparison
HL vs ASND Comparison
Compare HL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HL | ASND |
|---|---|---|
| Founded | 1891 | 2006 |
| Country | United States | Denmark |
| Employees | 1865 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 15.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | HL | ASND |
|---|---|---|
| Price | $16.46 | $268.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $21.13 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 27.6M | 723.8K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.92 | $96.35 |
| Revenue Next Year | N/A | $44.91 |
| P/E Ratio | $44.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.62 | $161.09 |
| 52 Week High | $34.17 | $274.89 |
Technical Indicators
Market Signals| Indicator | HL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 68.53 |
| Support Level | $16.46 | $213.28 |
| Resistance Level | $17.81 | N/A |
| Average True Range (ATR) | 0.76 | 10.66 |
| MACD | 0.20 | 4.52 |
| Stochastic Oscillator | 71.34 | 87.18 |
Price Performance
Historical ComparisonAbout HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.